Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists
Mr. Guscott et al., Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists, BEHAV PHARM, 11(6), 2000, pp. 495-504
In the rat, fear-potentiated startle (FPS) test animals are first trained t
o associate brief light presentations with a mild electric footshock and th
en tested for startle responses to acoustic stimuli, delivered either in da
rkness (i.e. baseline startle) or after the conditioning stimulus. Followin
g light presentation the magnitude of the startle response is markedly incr
eased, and the test is commonly used to distinguish anxiolytic drug effects
(i.e. a reduction in FPS) from non-specific effects such as sedation / mus
cle relaxation. However, recent studies suggest that the environment in whi
ch the animal is trained may also contribute towards the acquisition of a c
onditioned fear response (i.e. contextual fear conditioning) and that this
may elevate startle responses recorded in the dark In the present study, th
erefore, we have compared the benzodiazepine / gamma-aminobutyric acid-A re
ceptor agonist chlordiazepoxide with the partial agonists FG 8205 and breta
zenil, which are known to have a reduced propensity to produce sedation / m
yorelaxation, using two different FPS procedures: (i) conditioning and test
ing in stabilimeter chambers, and (ii) conditioning and testing in differen
t environments, The results show that FPS can be demonstrated in both proce
dures and that treatment with chlordiazepoxide, FG 8205 or bretazenil dose-
dependently attenuates the response. However, animals conditioned and teste
d in stabilimeter chambers also shelved a significant increase in dark-star
tle amplitudes compared with non-shocked rats, suggesting that this respons
e was elevated by contextual fear conditioning. Furthermore, despite clear
differences in side-effect liabilities, FG 8205 and bretazenil significantl
y reduced dark-startle responses, suggesting that this measure is also sens
itive to the anxiolytic effects of benzodiazepines. In contrast, when anima
ls were conditioned and tested in different environments, dark-startle resp
onses were not significantly different from those recorded in non-shocked r
ats and treatment with FG 8205 or bretazenil had no effect. Thus, condition
ing and testing animals in different environments may provide a more effect
ive means of distinguishing anxiolytic from non-specific drug effects in th
e rat FPS test. (C) 2000 Lippincott Williams & Wilkins.